EUVIMEDEUVIMED entdecken
Vergleichsstudie

Paired-eye comparison of photocoagulation versus intravitreal bevacizumab for retinopathy of prematurity: long-term visual, refractive, and ocular biometric outcomes at corrected ages 1, 5, and 9 years

Yoshimi Fukushima, Machi Takata, Akiteru Kawahara, Hideki Chuman, Nobuhisa Naoi, Yasuhiro Ikeda

Japanese Journal of Ophthalmology · 2026

DOI: 10.1007/s10384-026-01359-8 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Japanese Journal of Ophthalmology, 2026. Verfasst von Yoshimi Fukushima und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medicine, University of Miyazaki Hospital, 5200, Kihara, Kiyotake town, Miyazaki city, Miyazaki Pref., 889-16…. Hauptthemen laut MEDLINE: Bevacizumab, Retinopathy of Prematurity, Visual Acuity, Refraction, Ocular. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate long-term outcomes of photocoagulation (PC) and intravitreal bevacizumab (IVB) for retinopathy of prematurity (ROP). STUDY DESIGN: Retrospective paired-eye comparison. METHODS: Twenty-one patients (42 eyes) treated for ROP between 2009-2010 were included. In each subject, one eye received PC and the fellow IVB. Visual acuity (VA), refraction (spherical equivalent [SE], cylinder power [CP], corneal astigmatism [CA]), and ocular biometry (corneal curvature radius, anterior chamber depth [ACD], lens thickness [LT], and axial length [AL]) were assessed at corrected ages of 1, 5, and 9 years. Cross-sectional differences were analyzed using the Wilcoxon signed-rank test, with Bonferroni correction applied at 9 years. Annual rates of change were evaluated using a linear mixed-effects model (LMM). Inter-treatment differences were assessed using Spearman correlation analysis. RESULTS: At 9 years, PC-treated eyes showed significantly worse VA, greater myopia, and shorter AL (all p < 0.05). ACD was deeper in IVB-treated eyes, while CP and CA were greater in PC-treated eyes. LMM revealed a significantly faster progression of myopia and CP in PC-treated eyes. Conversely, the annual rates of ACD deepening and LT thinning were significantly faster in IVB-treated eyes, whereas no significant differences were observed for VA or AL. Inter-treatment differences in SE were significantly correlated with AL differences, whereas VA differences were correlated with ACD. CONCLUSION: IVB-treated eyes showed better VA, less myopia, and more favorable refractive and biometric parameters. SE differences were associated with AL, whereas VA differences were associated with ACD, indicating distinct structural mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BevacizumabRetinopathy of PrematurityVisual AcuityRefraction, OcularLaser CoagulationHumansRetrospective StudiesAngiogenesis InhibitorsIntravitreal InjectionsMaleFemaleBiometryFollow-Up StudiesChild, PreschoolInfantChildGestational AgeTreatment OutcomeCross-Sectional StudiesTime FactorsInfant, NewbornVascular Endothelial Growth Factor A

Stichwörter der Autor:innen

Intravitreal bevacizumabLaser photocoagulationLong-term outcomesPaired-eye comparisonRetinopathy of prematurity

Substanzen

BevacizumabAngiogenesis InhibitorsVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Ophthalmology, Faculty of Medicine, University of Miyazaki Hospital, 5200, Kihara, Kiyotake town, Miyazaki city, Miyazaki Pref., 889-1692, Japan. yofuku@med.miyazaki-u.ac.jp.
  • Inahara Ophthalmology Clinic, Miyazaki, Japan. yofuku@med.miyazaki-u.ac.jp.
  • Department of Ophthalmology, Faculty of Medicine, University of Miyazaki Hospital, 5200, Kihara, Kiyotake town, Miyazaki city, Miyazaki Pref., 889-1692, Japan.
  • Otsuka Komatsudai Eye clinic, Miyazaki, Japan.
  • Kawahara Ophthalmology Clinic, Miyazaki, Japan.
  • Miyazaki Chuoh Eye Hospital, Miyazaki, Japan.

Zitieren

APA

Fukushima, Y., Takata, M., Kawahara, A., Chuman, H., Naoi, N., & Ikeda, Y. (2026). Paired-eye comparison of photocoagulation versus intravitreal bevacizumab for retinopathy of prematurity: long-term visual, refractive, and ocular biometric outcomes at corrected ages 1, 5, and 9 years. Japanese Journal of Ophthalmology. https://doi.org/10.1007/s10384-026-01359-8

Vancouver

Fukushima Y, Takata M, Kawahara A, Chuman H, Naoi N, Ikeda Y. Paired-eye comparison of photocoagulation versus intravitreal bevacizumab for retinopathy of prematurity: long-term visual, refractive, and ocular biometric outcomes at corrected ages 1, 5, and 9 years. Japanese Journal of Ophthalmology. 2026. doi:10.1007/s10384-026-01359-8

BibTeX
@article{Fukushima2026,
  author = {Fukushima, Yoshimi and Takata, Machi and Kawahara, Akiteru and Chuman, Hideki and Naoi, Nobuhisa and Ikeda, Yasuhiro},
  title = {Paired-eye comparison of photocoagulation versus intravitreal bevacizumab for retinopathy of prematurity: long-term visual, refractive, and ocular biometric outcomes at corrected ages 1, 5, and 9 years},
  journal = {Japanese Journal of Ophthalmology},
  year = {2026},
  doi = {10.1007/s10384-026-01359-8}
}
Kostenlos starten →